Brad Loncar Spotlights Cancer Immunotherapy Index

Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment.

Episode metadata supplied by the publisher feed · Published Mar 8, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

Brad Loncar Spotlights Cancer Immunotherapy Index

0:00 18:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ETF Prime?

This episode is 18 minutes long.

When was this ETF Prime episode published?

This episode was published on March 8, 2016.

Can I download this ETF Prime episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!